pubmed.ncbi.nlm.nih.gov

Effectiveness of dietary allergen exclusion therapy on eosinophilic colitis in Chinese infants and young children ≤ 3 years of age - PubMed

  • ️Thu Jan 01 2015

Effectiveness of dietary allergen exclusion therapy on eosinophilic colitis in Chinese infants and young children ≤ 3 years of age

Min Yang et al. Nutrients. 2015.

Abstract

Eosinophilic colitis is a well recognized clinical entity mainly associated with food allergies. Empiric treatment options include dietary allergen exclusion (extensively hydrolyzed protein formula and elimination diet), anti-allergy medications (antihistamines and leukotriene receptor antagonists) and corticosteroids. We evaluated the effectiveness of dietary antigen exclusion on clinical remission of eosinophilic colitis in infants and young children. We retrospectively reviewed charts of all infants and children ≤3 years of age who were diagnosed with eosinophilic colitis (defined as mucosal eosinophilia ≥20 hpf-1) from 1 January 2011 to 31 December 2013 at a tertiary children's hospital in China. Forty-nine children were identified with eosinophilic colitis. Elemental formula, simple elimination diet or combination therapy resulted in clinical improvement in 75%, 88.2% and 80% of patients, respectively. In conclusion, eosinophilic colitis in infants and children ≤3 years of age responded well to dietary allergen exclusion.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Flow diagram of patient group selection.

Figure 2
Figure 2

Treatment outcomes for infants and children with eosinophilic colitis.

Similar articles

Cited by

References

    1. Furuta G.T., Forbes D., Boey C., Dupont C., Putnam P., Roy S., Sabrá A., Salvatierra A., Yamashiro Y., Husby S., et al. Eosinophilic Gastrointestinal Diseases Working Group. Eosinophilic gastrointestinal diseases (EGIDs) J. Pediatr. Gastroenterol. Nutr. 2008;47:234–238. doi: 10.1097/MPG.0b013e318181b1c3. - DOI - PubMed
    1. Aceves S., Hirano I., Furuta G.T., Collins M.H. Eosinophilic gastrointestinal diseases—Clinically diverse and histopathologically confounding. Semin. Immunopathol. 2012;34:715–731. doi: 10.1007/s00281-012-0324-x. - DOI - PubMed
    1. Jawairia M., Shahzad G., Mustacchia P. Eosinophilic gastrointestinal diseases: Review and update. ISRN Gastroenterol. 2012;2012:463689. - PMC - PubMed
    1. DeBrosse C.W., Rothenberg M.E. Allergy and eosinophilic-associated gastrointestinal disorders (EGID) Curr. Opin. Immunol. 2008;20:703–708. doi: 10.1016/j.coi.2008.07.010. - DOI - PMC - PubMed
    1. Lucendo A.J. Eosinophilic diseases of the gastrointestinal tract. Scand. J. Gastroenterol. 2010;45:1013–1021. doi: 10.3109/00365521003690251. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources